Health
New gene therapy restores dystrophin protein in patients with Duchenne muscular dystrophy – News-Medical.Net
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based…
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section of the dystrophin protein that is missing in many DMD patients.
The approach, described online today in the journal Science Advances, could lead to a treatment for DMD and inform the treatment of other inherited diseases.
Thousands of different mutations causing Duchenne have been identified, but they…
-
Noosa News17 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News22 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
General24 hours agoVacherot becomes lowest-ranked ATP Masters winner after defeating his cousin Rinderknech in Shanghai
-
Noosa News5 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge